Drugs for Sexually Transmitted Infections
September 1, 2013 (Issue: 133)
Many infections can be transmitted during sexual contact.
The text and tables that follow include recommendations
for management of sexually transmitted
infections (STIs) other than HIV, viral hepatitis, and
enteric infections. Some of the...more
1. L Rahangdale et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis 2006; 33:106.
2. CDC. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010; 59 (No. RR-12).
3. E Pitsouni et al. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents 2007; 30:213.
4. MR Hammerschlag et al. Treatment of neonatal chlamydial conjunctivitis with azithromycin. Pediatr Infect Dis J 1998; 17:1049.
5. R Martin-Iguacel et al. Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur J Clin Microbiol Infect Dis 2010; 29:917.
6. TA Peterman et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145:564.
7. CS Bradshaw et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006; 193:336.
8. LE Manhart et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis 2013; 56:934.
9. VG Allen et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013; 309:163.
10. CDC. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR 2012; 61:590.
11. GA Bolan et al. The emerging threat of untreatable gonococcal infection. N Engl J Med 2012; 366:485.
12. CDC. Two new promising treatment regimens for gonorrhea. Additional treatment options urgently needed. Available at www.cdc.gov/nchhstp/newsroom/2013/Gonorrhea-Treatment-Trial-PressRelease.html. Accessed August 14, 2013.
13. DN Fredricks et al. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353:1899.
14. CH Livengood 3rd et al. Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol 2007; 110:302.
15. JR Schwebke and RA Desmond. Tinidazole vs metronidazole for the treatment of bacterial vaginosis. Am J Obstet Gynecol 2011; 204:211.
16. JD Sobel et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194:1283.
17. Drugs for vulvovaginal candidiasis. Med Lett Drugs Ther 2001; 43:3.
18. JD Sobel et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004; 351:876.
19. RD Kirkcaldy et al. Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010. Emerg Infect Dis 2012; 18:939.
20. D Soper. Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 2004; 190:281.
21. NM Zetola and JD Klausner. Syphilis and HIV infection: an update. Clin Infect Dis 2007; 44:1222.
22. IM el Ashmawy et al. Teratogenic and cytogenic effects of ivermectin and its interaction with P-glycoprotien inhibitor. Res Vet Sci 2011; 90:116.
23. Veregen: a botanical for treatment of genital warts. Med Lett Drugs Ther 2008; 50:15.
24. Cervarix - a second HPV vaccine. Med Lett Drugs Ther 2010; 52:37.
25. CDC. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010; 59:626.
26. CDC. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011; 60:1705.
27. Adult immunizations. Treat Guidel Med Lett 2011; 9:75.
28. A Wald et al. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex Transm Dis 2006; 33:529.
29. L Corey et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11.
30. Antiviral drugs. Treat Guidel Med Lett 2013; 11:19.
31. B Pasternak and A Hviid. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010; 304:859.
32. MR Golden et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005; 352:676.
33. CDC. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep 2008; 57(RR-9):1.
34. CDC. Guidance on the use of expedited partner therapy in the treatment of gonorrhea. Available at www.cdc.gov/std/ept/GC-Guidance.htm. Accessed August 14, 2013.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this issue? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
